EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial

Mayank Rai iD, Sadhana Misar iD, Reeya Gamne iD

F1000Research · 12.08.2024 · 13 · 9

DOI: 10.12688/f1000research.139568.3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift F1000Research, online erschienen am 12.08.2024. Verfasst von Mayank Rai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Datta Meghe Institute of Higher Education & Research, Wardha, Maharashtra, India. Hauptthemen laut MEDLINE: Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Not any.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In ayurveda, sciatica can be correlated to ‘ Grudhrasi’ under Vata Nanatmaja-Vyadhi (neurological disorders caused by Vata , one of the bodily humour). In this mainly bodily humours vata and kapha are vitiating producing symptoms like piercing pain, stiffness, twitching, numbness and pain radiating from lumbosacral region to lower limb up to the foot. Therapeutic plan includes stabilizing and bringing back the vitiated vata and kapha humours to equilibrium. The prevalence of sciatica varies considerably ranging from 3.8% in the working population to 7.9% in the nonworking population.

Aim

Comparative evaluation of efficacy of Rasonapinda and Trayodashang guggul as an adjuvant to katibasti (oil pooling therapy) in the management of Grudhrasi (Sciatica).

Objectives

To assess the efficacy of Rasonapinda as an adjuvant to katibasti in subjective and objective parameters of Grudhrasi (Sciatica). To assess the efficacy of Trayodashang guggul as an adjuvant to katibasti in subjective and objective parameters of Grudhrasi (Sciatica). To compare the efficacy of Rasonapinda and Trayodashang guggul as an adjuvant to katibasti in subjective and objective parameters. Standardisation of Rasonapinda (modified formvati).

Methods

In this study, a total of 60 patients will be enrolled and divided equally into two groups. In group A, Trayodashang Guggul 500 mg twice a day after meal with warm water for 30 days adjuvant with katibasti for the initial 7 days will be given. In group B, Rasonapinda 500 mg twice a day after meal with warm water adjuvant with katibasti for the initial 7 days will be given for 30 days.

Result

The result will be assessed on baseline of subjective and objective parameters and data will be compared after treatment.

Conclusions

It will be based on observations and results obtained.

Trial registration

CTRI No. - CTRI/2022/12/048534 Dated – 27/12/2022.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsHumansMaleFemaleAdultMiddle AgedTreatment OutcomeMedicine, AyurvedicPlant GumsCommiphora

Stichwörter der Autor:innen

GrudhrasiRasonapindaRukaSciaticadashmool taila.katibastikatipradeshtrayodashang guggul

Substanzen

Plant Extractsguggulu extractPlant Gums

Autor:innen und Institutionen

  • Datta Meghe Institute of Higher Education & Research, Wardha, Maharashtra, India.

ORCID-Profile: Mayank Rai, Sadhana Misar, Reeya Gamne

Förderung

  • Not any

Zitieren

APA

Rai, M., Misar, S., & Gamne, R. (2024). Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial. F1000Research, 13, 9. https://doi.org/10.12688/f1000research.139568.3

Vancouver

Rai M, Misar S, Gamne R. Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial. F1000Research. 2024;13:9. doi:10.12688/f1000research.139568.3

BibTeX
@article{Rai2024,
  author = {Rai, Mayank and Misar, Sadhana and Gamne, Reeya},
  title = {Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial},
  journal = {F1000Research},
  year = {2024},
  volume = {13},
  pages = {9},
  doi = {10.12688/f1000research.139568.3}
}
Kostenlos starten →